6 - Magnolia A - Oncology
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
| 2:45 PM | Brian Crossley, Beth Israel Deaconess Medical Center | Testosterone Breakthrough Risk with Eligard® vs Lupron® During Drug Shortage |
| 3:00 PM | Katelin Ivey, Geisinger Medical Center | Incidence of Febrile Neutropenia in Cyclin-Dependent Kinase Inhibitors |
| 3:15 PM | Krishna Patel, Robert Wood Johnson University Hospital | Impact of Pre- and Post-Subcutaneous Daratumumab Implementation on the Rate of Hypersensitivity Reactions |
| 3:30 PM | Sydney Tu, Massachusetts General Hospital | Inpatient Use of Leuprolide in Oncology Patients |
| 3:45 PM | Kathryn Rechenberg, Massachusetts General Hospital | Therapeutic Enoxaparin Dosing in Thrombocytopenic Leukemia Patients |
| 4:00 PM | Kyle Lamb, Hospital of the University of Pennsylvania | Characterization of Outcomes of Delayed Immunotherapy Initiation in Extensive Stage Small Cell Lung Cancer Patients |
| 4:15 PM | Alyssa Cendagorta, University of Rochester Medical Center | Evaluation of clotting and bleeding risk associated with the use of asparaginase products in patients with acute lymphoblastic leukemia |
| 4:30 PM | Slavka Simic, Englewood Hospital and Medical Center | Evaluation of Biosimilar Utilization Following Implementation of Oncology Computerized Physician Order Entry (CPOE) at a Community Hospital |
Brian Crossley
Katelin Ivey
Krishna Patel
Sydney Tu
Kathryn Rechenberg
Kyle Lamb
Alyssa Cendagorta
Slavka Simic
Mark Attilio (Moderator)
Tamara Kitsul (Moderator)
Key:
Complete
Next
Failed
Available
Locked
6 - Magnolia A - Oncology
05/18/2022 at 2:45 PM (EDT) | 120 minutes
05/18/2022 at 2:45 PM (EDT) | 120 minutes